Quoin Pharmaceuticals Ltd DRC • QNRX

Capital at risk.

About Quoin Pharmaceuticals Ltd DRC
Ticker
info
QNRX
Trading on
info
NASDAQ
ISIN
info
US74907L1026
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Dr. Michael Myers Ph.D.
Headquarters
info
42127 Pleasant Forest Court, Ashburn, VA, United States, 20148-7349
Employees
info
3
Website
info
https://quoinpharma.com
Quoin Pharmaceuticals, Ltd., a late stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). It also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat Netherton Syndrome; and QRX008 for the treatment of scleroderma. It has a research agreement with Queensland University of Technology; a license agreement with Skinvisible Inc.; consulting agreements with Axella Research LLC; and a Master Service Agreement with Therapeutics Inc. Quoin Pharmaceuticals, Ltd. was founded in 2018 and is based in Ashburn, Virginia. Quoin Pharmaceuticals, Ltd. is a subsidiary of Skinvisible, Inc.
Metrics
BasicAdvanced
Market cap
info
$4.9M
P/E ratio
info
0.01
EPS
info
$958.65
Dividend Yield
info
0.00%
Beta
info
1.96
Forward P/E ratio
info
0
EBIDTA
info
$-14.1M
Ex dividend date
info
-
Price & volume
Market cap
info
$4.9M
Average daily volume
info
1M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0.01
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0.01
Price to sales
info
0
Price to book
info
1.92
Earnings
EPS
info
$958.65
EPS estimate (current quarter)
info
-$1.92
EPS estimate (next quarter)
info
-$1.97
EBITDA
info
$-14.1M
Revenues (TTM)
info
$0M
Revenues per share (TTM)
info
$0.00
Technicals
Beta
info
1.96
52-week High
info
$32.10
52-week Low
info
$5.01
50-day moving average
info
$9.84
200-day moving average
info
$8.96
Short ratio
info
0.1
Short %
info
14.26%
Management effectiveness
ROE (TTM)
info
-651.40%
ROA (TTM)
info
-99.47%
Profit margin
info
0.00%
Gross profit margin
info
$0M
Operating margin
info
0.00%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
0.00%
Share stats
Outstanding Shares
info
0.6M
Float
info
22.4M
Insiders %
info
6.82%
Institutions %
info
3.99%
Analyst Insights & forecasts
info

100% Buy

0% Hold

0% Sell

Based on information from 2 analysts.

Average price target

info
$40.67
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.28
-$0.43
35.33%
Q4 • 24Beat
-$6.50
-$4.20
-54.81%
Q1 • 25Missed
-$6.30
-$0.56
-1,025.00%
Q2 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$0M
$-3.7M
-∞%
Q2 • 25
$-3.9M
0.00%
Q3 • 25
NaN%
6.82%
0.00%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$8.9M
$6.4M
71.37%
Q2 • 25
$6.4M
$7.6M
118.91%
Q3 • 25
-27.93%
20.08%
66.60%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-3.7M
$1.7M
$-0.2M
$-3.7M
Q2 • 25
$-2.2M
-
$-0.2M
$-2.2M
Q3 • 25
-39.63%
-
-0.00%
-39.63%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Quoin Pharmaceuticals Ltd DRC share?
Collapse

Quoin Pharmaceuticals Ltd DRC shares are currently traded for undefined per share.

How many shares does Quoin Pharmaceuticals Ltd DRC have?
Collapse

Quoin Pharmaceuticals Ltd DRC currently has 0.6M shares.

Does Quoin Pharmaceuticals Ltd DRC pay dividends?
Collapse

No, Quoin Pharmaceuticals Ltd DRC doesn't pay dividends.

What is Quoin Pharmaceuticals Ltd DRC 52 week high?
Collapse

Quoin Pharmaceuticals Ltd DRC 52 week high is $32.10.

What is Quoin Pharmaceuticals Ltd DRC 52 week low?
Collapse

Quoin Pharmaceuticals Ltd DRC 52 week low is $5.01.

What is the 200-day moving average of Quoin Pharmaceuticals Ltd DRC?
Collapse

Quoin Pharmaceuticals Ltd DRC 200-day moving average is $8.96.

Who is Quoin Pharmaceuticals Ltd DRC CEO?
Collapse

The CEO of Quoin Pharmaceuticals Ltd DRC is Dr. Michael Myers Ph.D..

How many employees Quoin Pharmaceuticals Ltd DRC has?
Collapse

Quoin Pharmaceuticals Ltd DRC has 3 employees.

What is the market cap of Quoin Pharmaceuticals Ltd DRC?
Collapse

The market cap of Quoin Pharmaceuticals Ltd DRC is $4.9M.

What is the P/E of Quoin Pharmaceuticals Ltd DRC?
Collapse

The current P/E of Quoin Pharmaceuticals Ltd DRC is 0.01.

What is the EPS of Quoin Pharmaceuticals Ltd DRC?
Collapse

The EPS of Quoin Pharmaceuticals Ltd DRC is $958.65.

What is the PEG Ratio of Quoin Pharmaceuticals Ltd DRC?
Collapse

The PEG Ratio of Quoin Pharmaceuticals Ltd DRC is null.

What do analysts say about Quoin Pharmaceuticals Ltd DRC?
Collapse

According to the analysts Quoin Pharmaceuticals Ltd DRC is considered a buy.